EyeWorld Weekly, June 28, 2024

➤ Prospective trial reveals impact of home OCT in wet AMD management ➤ Devices receive FDA 510(k) clearance ➤ Review date set for BLA for treatment of macular telangiectasia type 2 ➤ FDA grants IND to gene therapy for patients with geographic atrophy ➤ Acquisition news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, June 28, 2024